Description
Cagrilintide 5mg + Semaglutide 5mg
Cagrilintide 5mg + Semaglutide 5mg, the combination of Cagrilintide 5mg + Semaglutide 5mg represents a next-generation dual-agonist approach to obesity treatment. By targeting both GLP-1 and amylin receptors simultaneously, it achieves greater weight loss than either mechanism alone.


Reviews
There are no reviews yet.